Join a conversation with Stéphane Bancel, CEO of Moderna Therapeutics, as he describes the science, business, and policy issues surrounding the first, and currently only, company with a vaccine for coronavirus in clinical trials with the National Institute of Health (NIH). Following the lecture, Professor Andrew W. Lo will moderate a fireside chat to discuss this important challenge.
Mr. Bancel will discuss the effort to produce a batch of vaccines ready for clinical trials - from sequence identification through vaccine design, manufacturing, and shipment - in only 42 days.
Hosted by MIT LFE, MIT GCFP, and Moderna Therapeutics.
The webinar link will be sent out to registered participants by Monday, March 30th.
To submit questions for the fireside chat or make inquiries, please email Crystal Myler at email@example.com.